logo
Select company
Select metric
$ -17.08MConsolidated Income
VS
Market
30
Sector
59
Industry
72
History
32
$ 4.96Close
$ 1.02 - $ 5.63 52-Week Range
Ticker Information

Ticker

ENTO

Company Name

ENTERO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ENTERO THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ENTO - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -17.08M
3/31/2025$ -24.89M
12/31/2024$ -18.06M
9/30/2024$ -9.92M
6/30/2024$ -10.78M
3/31/2024$ -6.16M
12/31/2023$ -15.79M
9/30/2023$ -15.68M
6/30/2023$ -7.85M
3/31/2023$ -9.07M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ENTERO THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -16.55M.
  • Over the past 5 years, ENTERO THERAPEUTICS INC's average Cons. Inc. has been $ -26.81M.
  • The median Cons. Inc. for ENTERO THERAPEUTICS INC during this period was $ -17.57M
  • ENTERO THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ -6.16M.
  • The lowest Cons. Inc. recorded by ENTERO THERAPEUTICS INC in the same timeframe $ -64.77M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

ENTO - Consolidated Income, Last 5 years

$ -64.77M

Minimum

Sep 30, 2021

$ -6.16M

Maximum

Mar 31, 2024

$ -26.81M

Average

$ -17.57M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.05M with a standard deviation of $ 116.48M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.05M
median$ -2.09M
std$ 116.48M